The global pediatric market essentially comprises of the healthcare services provided across various areas of healthcare industry. Children are often prone to illness and diseases and catch infections easily. Hence the pediatric market in terms of healthcare is a flourishing one, no matter what. Changes in lifestyle and unhealthy habits prevailing in the family largely contribute to the growth of this market.
The global pediatric market is valued to be $XX billion in 2015 and is poised to grow at a steady CAGR of X% to reach $XX billion by the end of forecast period. The steady growth can be attributed to the increasing complications and health issues in infants and children.
The global pediatric market is dominated by the Americas in 2015, which accounted for a market of x% of the global market revenue. They are followed by Europe, which is poised to grow at a CAGR of X%. Asia-Pacific is estimated to be the fastest growing region during the period under study owing to the rapid technological advances in medicine going on in the developing economies such as China and India.
The global market for pediatric interventional cardiology in 2014 is largely dominated by the Americas, especially in the U.S. due to the increasing instances of cardiac diseases among the children. APAC region is poised to exhibit highest growth rate during the forecast period due to the flooding investments in pediatrics by major healthcare players in this region, especially from China and India. The improved healthcare services and governmental healthcare reforms and increased awareness among people drive the market for pediatric interventional cardiology in the APAC region.
Profiled in this Report are:
- Claritas Genomics, Inc.
- Clarity Medical Systems, Inc.
- Covidien Public Limited Company
- Edwards Lifesciences
- Envision Radiology
1. Global Pediatric Market Overview
2. Executive Summary
3. Global Pediatric Market Landscape
3.1. Pediatric Market share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End-User Profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financial Analysis
4. Global Pediatric Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Global Pediatric Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Product Life Cycle Analysis
5.5. Suppliers & Distributors
6. Global Pediatric Market – By Infant Care Services
6.2. Pediatric Interventional Cardiology
6.3. Pediatric Medical Imaging
6.4. Pediatric Monitoring
6.5. Pediatric Diagnostics
7. Global Pediatric Interventional Cardiology Market – By Technique
7.2.4. Stent Implantation
7.3. Transcatheter Coil Occlusion
8. Global Pediatric Medical Imaging Market – By Imaging Technique
8.2. Conventional X-ray
8.4. Computed Tomography (CT)
9. Global Pediatric Monitoring Market – By Service
9.2. Vital Signs Monitoring
9.3. Blood-Oxygen Level Monitoring
9.4. Cardiac/ECG Monitoring
9.5. EEG Monitors
9.6. CO2 Monitoring
9.8. Temperature monitoring
10. Global Pediatric Market – By Geography
10.4.4. South Korea
10.5.1. Middle East
11. Pediatric Market Entropy
11.1. New Product Launches
11.2. M&As, Collaborations, Partnerships & JVs
12. Investment Opportunities
13. Pediatric Market Company Profiles
13.1. Boston Scientific Corporation
13.2. Claritas Genomics, Inc.
13.3. Clarity Medical Systems, Inc.
13.4. Covidien Public Limited Company
13.5. Edwards Lifesciences
13.6. Envision Radiology
13.7. EOS Imaging SA
13.8. GE Healthcare
13.9. Infinium Medical, Inc.
13.10. NextCODE Health
13.11. Numed, Inc.
13.12. PDI Pediatric Teleradiology
13.13. Pediatric Bioscience, Inc.
13.14. Pureform & PureKids Radiology
13.15. Quest Diagnostics Incorporated
13.16. Sheffield Children's Hospital
13.17. Siemens Healthcare
13.18. St. Jude Medical
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
14.3. Research Methodology
14.5. Compilation of Expert Insights